Join us in advancing our understanding of gestational diabetes mellitus (GDM)
Do you want to help improve management of gestational diabetes while advancing our understanding of the science behind GDM? Sign up for our ongoing and future IRB studies.
THE STATISTICS ARE ALARMING. WOMEN DIAGNOSED WITH GDM HAVE...
greater likelihood of an emergency C-Section
(J Obstet Gynaecol Res 2012)
1.5X
greater likelihood of having a preterm birth
(Obstetrics and Gynecology 2003)
>50%
greater likelihood of developing type II diabetes
(Centers for Disease Control and Prevention)
1.4x
LEARN MORE
OVER 80% OF PREGNANCY-RELATED DEATHS ARE PREVENTABLE ACCORDING TO A NEW CDC REPORT
nearly 7 million women in the U.S. have low or no access to maternity care and more than 1 in 3 counties have NO obstetric hospitals/birth centers and NO obstetric providers
gestational diabetes rates increased 30% between 2016 - 2020, with an increase of 13% during the first year of the pandemic alone
A retrospective study in women with GD found several independent predictors of postpartum glucose metabolism disorders + T2D such as BMI, early GD diagnosis, 3rd trimester HbA1c
Obstetric & neonatal complications SUCH AS preeclampsia, cesarean section, shoulder dyStocia & asphyxia remain prevalent among mothers with GD
A case report of 70 patients found that individuals with GD were more likely to experience food insecurity that those without
Lower glycemic criteria for the diagnosis of gestational diabetes do not reduce the risk of a large-for-gestational-age infant
PATIENTS wITH GESTATIONAL DIABETES experience stigma as overt discrimination, internalized guilt + shame. Consequences: patients are unable to follow dietary recommendations and blood glucose logging, experience social isolation, and have worsened mental health
Dysregulated exosomal miRNAs in plasma from GDM pregnant women might influence the insulin and AMPK signaling pathways and could contribute to the early prediction of GDM
Managing GD in 2019 cost the u.s. $4.8 billion - the third highest condition after mental health and hypertensive disorders
we are currently recruiting patients
mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDM
Frequently Asked Questions
Am I eligible to participate?
If you are at least 18 years old and live in the United States, then you're eligible to participate
What is the purpose of the study?
We want to learn more about who gestational diabetes affects, and how we can improve management of gestational diabetes. If you have been diagnosed with gestational diabetes, take our survey so we can better understand the unique pain points of managing your condition.
What are the possible benefits of taking part?
In addition to advancing our understanding of management of diabetes during pregnancy, you will be invited to participate in our full clinical trial with Stanford Healthcare beginning late 2022.
Are there any possible disadvantages or risks from taking part?
This is a low-risk study that requires <10 minutes of your time
Do I have to participate?
No, it’s completely voluntary
How can I get more involved?
Drop us a line at research@heymalama.com and we'll add you to our list of beta app users so that you can get immediate access to our app, and help shape the product for future moms with GDM!
Get notified about upcoming studies!
Stay in the loop on upcoming study opportunities.
